Solution Oligonucleotide APIs: Regulatory Considerations

Manufacture of oligonucleotide active pharmaceutical ingredients (APIs) typically consists of solid-phase synthesis, deprotection and cleavage, purification and filtration, and isolation from aqueous solutions through lyophilization. In the first step of drug product manufacture, the API is dissolve...

Descripción completa

Detalles Bibliográficos
Autores principales: Wetter, Christian, Chorley, Chris, Curtis, Corrine, del Canto, Nicole, Ford, J. Gair, Franklin, Jennifer, Gazziola, Cinzia, Jones, Michael T., Lee, Judy, McAuley, Arnold, Saraber, Florence C. E., Scott, Audrey, Tom, Janine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964572/
https://www.ncbi.nlm.nih.gov/pubmed/35133632
http://dx.doi.org/10.1007/s43441-022-00384-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964572/
https://www.ncbi.nlm.nih.gov/pubmed/35133632
http://dx.doi.org/10.1007/s43441-022-00384-2

Ejemplares similares